BioCentury | Apr 13, 2009
Clinical News

TerbiMed: Phase II data

...MedPharm said a short dosing regimen of TerbiMed met the primary endpoint of non-inferiority to Lamisil...
...Switzerland) markets Lamisil to treat onychomycosis and tinea capitis. MedPharm Ltd. , Charlbury, U.K. Product: TerbiMed...
...Molecular target: Not applicable Description: Dry, transparent film of terbinafine applied on the skin using MedSpray...
BioCentury | Mar 9, 2009
Company News

MedPharm, Moberg Derma, Zelmic AB deal

...Moberg received an exclusive, worldwide license to use MedPharm's MedSpray sprayable drug delivery technology to develop...
BioCentury | Nov 19, 2007
Clinical News

MedSpray: Phase II start

...Phase II trial of MedSpray using an undisclosed antifungal. MedPharm Ltd. , Charlbury, U.K. Product: MedSpray...
Items per page:
1 - 3 of 3